A large number of breast cancer patients in the U.S. have taken Sanofi's chemotherapy drug, Taxotere, to treat various forms of cancer. Many women who were left with permanent hair loss from the drug are filing lawsuits against Sanofi, the manufacturer of Taxotere. Hair loss is a known side effect of many cancer treatments, but it is only temporary in most treatments. Sanofi failed to warn patients taking Taxotere that their drug could cause permanent hair loss when they knew that this was a known side effect.
Despite informing patients who used their cancer drug in other countries, Sanofi did not warn women in the U.S. The words “permanent hair loss” or “alopecia”, the technical word for the condition of permanent hair loss, do not appear in any information published by Sanofi in the U.S. in regard to Taxotere according to lawsuits.
This failure to warn removed the choice of patients in their decision to use or not use Taxotere, to risk permanent hair loss by using this drug. That decision making process was denied to Taxotere patients in U.S. by the decision of Sanofi to not warn.
If you or a loved one has taken Taxotere and been a victim of permanent hair loss, please call our law firm today at 1-214-522-9999 and let us evaluate your case.
